A hyaluronic acid modified advanced nanoagent activated by tumor microenvironment enables a reciprocal dual-modality therapy
Jiaxuan Li,
No information about this author
Zelong Chen,
No information about this author
Zhichao Pei
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 159884 - 159884
Published: Feb. 1, 2025
Language: Английский
Plasmonic Nanodiamond – Microneedle Bioinspired System for Ultrarapid Sampling and Quantum Sensing of Melanoma‐Related MiRNA
Min Wu,
No information about this author
Lei Liu,
No information about this author
Youqiang Xing
No information about this author
et al.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 5, 2025
Abstract
MicroRNA
(miRNA)
in
interstitial
fluid
(ISF)
is
a
promising
biomarker
for
early
disease
diagnosis,
but
its
quantification
challenging
due
to
low
sampling
efficiency
and
weak
signals.
Here,
inspired
by
the
osmotic
pressure‐driven
feeding
mechanism
of
sea
anemones,
novel
designed
that
plasmonic
nanodiamonds
–
microneedles
(PND‐MNs)
bioinspired
system
ultrarapid
quantum
sensing
melanoma‐related
miRNA.
Specifically,
high‐osmotic
hydrogel
microneedles,
prepared
immersing
LiCl
solution,
exhibit
substantial
swelling
ratio
rapid
ISF
enrichment,
extracting
0.92
±
0.14
mg
within
5
min.
Concurrently,
coating
fluorescent
(FNDs)
with
hollow
composite
metal
Au‐Ag
NPs,
precise
modulation
fluorescence
intensity
nitrogen
vacancy
color
centers
(NV‐center)
FNDs
has
been
achieved.
This
innovative
technology
significantly
enhances
signal
PND‐MNs
system,
amplifying
it
factor
16,
reducing
detection
limit
miRNA
an
unprecedented
0.68
f
m
(to
knowledge,
no
method
based
on
detecting
biomarkers
surpassed
this
level).
Furthermore,
employing
backpropagation
neural
network
(BPNN),
achieves
high
accuracy
recognizing
concentrations
(R
2
=
0.9986).
By
combining
sampling,
enhancement,
machine
learning,
holds
promise
biomarkers,
offering
significant
clinical
applications.
Language: Английский
Mitochondrial-Targeted Multifunctional Platinum-Based Nano “Terminal-Sensitive Projectile” for Enhanced Cancer Chemotherapy Efficacy
Qiang Zhang,
No information about this author
Jiamin Lin,
No information about this author
Jun Li
No information about this author
et al.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 25, 2025
Platinum-based
anticancer
drugs
exert
their
effects
by
forming
adducts
within
nuclear
DNA
(nDNA),
inhibiting
transcription
and
inducing
apoptosis
in
cancer
cells.
However,
tumor
cells
have
evolved
mechanisms
to
resist
these
drugs.
Given
mitochondria's
role
lack
of
nucleotide
excision
repair
(NER),
targeting
mitochondrial
(mtDNA)
offers
a
strategy.
Herein,
platinum-based
terminal-sensitive
projectile
(TSB)
which
comprises
heterofunctional
tetravalent
platinum
prodrug
as
the
primary
warhead,
complemented
guidance
system
incorporating
triphenylphosphine
(TPP)
secondary
FFa
(Fenofibric
acid)
was
developed.
TSB
then
encapsulated
IR780
coupling
DSPE-PEG2K
for
enhanced
delivery
(NTSB).
This
design
allows
be
precisely
targeted
into
intertumoral
mitochondria
its
terminal,
releasing
free
oxaliplatin
(OXA)
upon
reaching
terminal
destination.
The
accumulation
OXA
leads
cross-linking
with
mtDNA,
causing
dysfunction,
while
disrupts
electron
transport
chain
(ETC),
impairing
oxidative
phosphorylation
(OXPHOS).
Furthermore,
under
near-infrared
(NIR)
irradiation,
component
generates
phototherapeutic
thermal
effect
reactive
oxygen
species
(ROS),
deplete
intracellular
glutathione
(GSH)
levels
facilitate
Pt
mtDNA.
Both
vitro
vivo
studies
demonstrated
that
this
comprehensive
approach
significantly
enhances
sensitivity
chemotherapeutic
Language: Английский